Arcus Biosciences RCUS Business Segments — Interest income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's business segments — interest income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's business segments — interest income, net?
- Arcus Biosciences (RCUS) reported business segments — interest income, net of -$6M in Q1 2026.
- How has Arcus Biosciences's business segments — interest income, net changed year-over-year?
- Arcus Biosciences's business segments — interest income, net increased by 40.0% year-over-year, from -$10M to -$6M.
- What is the long-term trend for Arcus Biosciences's business segments — interest income, net?
- Over 3 years (2022 to 2025), Arcus Biosciences's business segments — interest income, net has grown at a 36.4% compound annual growth rate (CAGR), from -$13M to -$33M.
- What does business segments — interest income, net mean?
- Reflects the net earnings generated from cash and investment balances held by the segment, offset by any interest expenses incurred. It provides insight into the segment's treasury management and the yield on its liquid assets.